Cnf1 Variants Endowed with the Ability to Cross the Blood–Brain Barrier: A New Potential Therapeutic Strategy for Glioblastoma

Among gliomas, primary tumors originating from glial cells, glioblastoma (GBM) identified as WHO grade IV glioma, is the most common and aggressive malignant brain tumor. We have previously shown that the Escherichia coli protein toxin cytotoxic necrotizing factor 1 (CNF1) is remarkably effective as...

Descripción completa

Detalles Bibliográficos
Autores principales: Colarusso, Andrea, Maroccia, Zaira, Parrilli, Ermenegilda, Germinario, Elena Angela Pia, Fortuna, Andrea, Loizzo, Stefano, Ricceri, Laura, Tutino, Maria Luisa, Fiorentini, Carla, Fabbri, Alessia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290510/
https://www.ncbi.nlm.nih.gov/pubmed/32375387
http://dx.doi.org/10.3390/toxins12050291

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290510/
https://www.ncbi.nlm.nih.gov/pubmed/32375387
http://dx.doi.org/10.3390/toxins12050291

Ejemplares similares